The first FDA-approved at-home cervical cancer screening device launched this week in California. Why it matters: Cervical ...

The Nobel Prize-winning technology underpinning COVID-19 vaccines is also fueling a host of biotechs developing treatments ...

But a report released Wednesday by the Centers for Disease Control and Prevention indicates that young adults have their fair share of health woes. A third of 18- to 29-year-olds, a demographic the ...

Researchers have 3D printed structures inside a living cell. This seems to be the very first time this has been achieved, done by Slovenian researchers. They were able to 3D print multiple example ...

The improvement happened swiftly. In 2017, Denmark started offering an HPV vaccine covering 4 strains. Before the vaccination ...

Thirty-four point three and 37.6% of US adults were reportedly unaware of HPV and lacked awareness about the HPV vaccine, respectively.

The FDA approved the adenoviral vector-based immunotherapy, zopapogene imadenovec-drba, for treatment of certain patients ...

Schrödinger announced it will discontinue clinical development of the CDC7 inhibitor SGR-2921 for acute myeloid leukemia (AML) and myelodysplastic syndromes following two patient deaths in an ...

Papzimeos is the first immunotherapy approved for recurrent respiratory papillomatosis, a rare lung disorder involving the ...

The FDA’s announcement of Papzimeos’ approval contained an unusual quote from newly reinstated CBER director Vinay Prasad. Elsewhere, Eli Lilly and Superluminal Medicines struck a deal.

For the first time, the FDA has approved a treatment for recurrent respiratory papillomatosis (RRP), a rare, chronic disease that causes benign tumors, most commonly in the voice box, and can force ...

NEW YORK, Aug. 15, 2025 /PRNewswire/ -- With thousands of press releases published each week, it can be difficult to keep up ...